Evidence map›Paper›PMID 22291014›Full record

ArticleThe Journal of biological chemistry2012

Structural and biochemical characterization of human mitochondrial branched-chain α-ketoacid dehydrogenase phosphatase.

R Max Wynn, Jun Li, Chad A Brautigam, Jacinta L Chuang, David T Chuang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Structure-based design and mechanisms of allosteric inhibitors for mitochondrial branched-chain α-ketoacid dehydrogenase kinase.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

R Max WynnDepartment of Biochemistry, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9038, USA. richard.wynn@utsouthwestern.edu
Jun Li
Chad A Brautigam
Jacinta L Chuang
David T Chuang
The University of Texas Southwestern Medical Center · USSouthwestern Medical Center · US

Funding

Structure and Function of Mitochondrial Protein KinasesR01DK062306 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI CHUANG, DAVID T · 2003 to 2018
$5.4M
INBORN ERRORS OF METABOLISM IN CELL CULTURER01DK026758 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI CHUANG, DAVID T · 1986 to 2010
$4.3M
Phenylbutyrate therapy for maple syrup urine diseaseR01DK092921 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI LEE, BRENDAN · 2011 to 2015
$3.3M
Structure and Function of Mitochondrial Protein KinasesR56DK062306 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI CHUANG, DAVID T · 2008 to 2014
$397k
NIDDK NIH HHS DK26758NIDDK NIH HHS DK62306NIDDK NIH HHS DK92921NIDDK NIH HHS R01 DK026758NIDDK NIH HHS R01 DK062306NIDDK NIH HHS R01 DK092921NIDDK NIH HHS R56 DK062306
6 · The paper itself

Abstract

The branched-chain α-ketoacid dehydrogenase phosphatase (BDP) component of the human branched-chain α-ketoacid dehydrogenase complex (BCKDC) has been expressed in Escherichia coli and purified in the soluble form. The monomeric BDP shows a strict dependence on Mn(2+) ions for phosphatase activity, whereas Mg(2+) and Ca(2+) ions do not support catalysis. Metal binding constants for BDP, determined by competition isothermal titration calorimetry, are 2.4 nm and 10 μm for Mn(2+) and Mg(2+) ions, respectively. Using the phosphorylated decarboxylase component (p-E1b) of BCKDC as a substrate, BDP shows a specific activity of 68 nmol/min/mg. The Ca(2+)-independent binding of BDP to the 24-meric transacylase (dihydrolipoyl transacylase; E2b) core of BCKDC results in a 3-fold increase in the dephosphorylation rate of p-E1b. However, the lipoyl prosthetic group on E2b is not essential for BDP binding or E2b-stimulated phosphatase activity. Acidic residues in the C-terminal linker of the E2b lipoyl domain are essential for the interaction between BDP and E2b. The BDP structure was determined by x-ray crystallography to 2.4 Å resolution. The BDP structure is dominated by a central β-sandwich. There are two protrusions forming a narrow cleft ∼10 Å wide, which constitutes the active site. The carboxylate moieties of acidic residues Asp-109, Asp-207, Asp-298, and Asp-337 in the active-site cleft participate in binding two metal ions. Substitutions of these residues with alanine nullify BDP phosphatase activity. Alteration of the nearby Arg-104 increases the K(m) for p-E1b peptide by 60-fold, suggesting that this residue is critical for the recognition of the native p-E1b protein.

Indexed as

Amino Acid SequenceCatalytic DomainCrystallography, X-RayHumansKineticsMagnesiumMitochondriaModels, MolecularMolecular Sequence DataPhosphoprotein PhosphatasesProtein Phosphatase 2CMagnesiumPhosphoprotein PhosphatasesPPM1K protein, humanProtein Phosphatase 2C

Identifiers

PMID22291014
PMCPMC3308798
OpenAlexW2156405606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.